"Breakthrough Vaccine Offers Hope in the Fight Against Deadly Meningitis"
The CDC's independent vaccine advisors have recommended a new pentavalent meningococcal vaccine, Penbraya, developed by Pfizer, which protects against five types of bacteria that cause meningococcal disease. Currently, there are two types of meningococcal vaccines in the US: the MenACWY vaccine, which protects against four groups of bacteria, and the MenB vaccine, which protects against a different group. The new vaccine could offer broad protection with fewer shots, potentially simplifying the vaccination schedule and increasing coverage. Meningococcal disease, including meningitis, can be deadly or lead to long-term medical problems, and early diagnosis is crucial for effective treatment. The CDC will need to accept the committee's recommendation for it to become official.